<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Evasion from cytotoxic T-lymphocyte (CTL) surveillance may be an important step in the pathogenesis of Epstein-Barr virus (EBV)-carrying Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) as suggested by the consistent down-regulation of <z:hpo ids='HP_0000001'>all</z:hpo> transformation-associated <z:mp ids='MP_0001799'>viral</z:mp> antigens, except EBV nuclear antigen 1 (EBNA-1), and of certain HLA class I alleles in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> biopsies and cell lines that maintain the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0005384'>cell phenotype</z:mp> in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>The most common HLA class I defect recorded in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines is a selective down-regulation of HLA-A11 </plain></SENT>
<SENT sid="2" pm="."><plain>To gain some insight into the role of HLA-A11 down-regulation in pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, we have investigated the target specificity of HLA-A11-restricted CTLs derived by stimulation of lymphocytes from three EBV-seropositive individuals with autologous EBV-transformed lymphoblastoid cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Recombinant <z:e sem="disease" ids="C0042214" disease_type="Disease or Syndrome" abbrv="">vaccinia</z:e> viruses carrying the coding sequences for EBNA-1, -2A, -2B, -5, -3, -4, and -6 (also known as EBNA-1, -2A, -2B, -LP, -3a, -3b, and -3c, respectively) and EBV latent membrane protein 1 were used to induce high levels of expression of the relevant EBV antigen in fibroblasts derived from HLA class I-matched individuals </plain></SENT>
<SENT sid="4" pm="."><plain>EBNA-4-expressing fibroblasts were the predominant target of HLA-A11-restricted CTLs in <z:hpo ids='HP_0000001'>all</z:hpo> three donors </plain></SENT>
<SENT sid="5" pm="."><plain>A less pronounced and less regular EBNA-6-specific cytotoxic component was found in two of the donors </plain></SENT>
</text></document>